News AZ's Tagrisso looks set for first-line lung cancer label in ... Expanded label likely in coming weeks
News BMS' Opdivo shines as infectious disease franchise fades Bristol-Myers Squibb has been touted as a potential takeover target in the pharma industry – and potential buyers may take note of the continued strong performance of its cancer drug Opdivo
News Novel cancer immunotherapy research lands Innovate UK fundin... New programme will leverage well-validated genetic mechanisms to promote cancer immunity.
News Mixed results from Roche's key new drugs in Q1 Lacklustre performance from GSK as results season begins
Events Partner Content Immuno-Oncology Immuno-Oncology Main Conference: 26 – 27 September 2018 Pre-Conference Workshops: 25 September 2018 Copthorne Tara Hotel, London, UK
News AI giant Anthropic buys Coefficient Bio for $400m Anthropic has continued its push into the healthcare sector by acquiring New York startup Coefficient Bio.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
